Electronic Health Reporter
OCTOBER 25, 2019
UC Riverside’s Wet Lab Incubator has opened its doors to biotech entrepreneurs throughout the Inland Empire. The article UC Riverside’s Wet Lab Incubator Open To Biotech Entrepreneurs appeared first on electronichealthreporter.com. These innovators will no longer have […]. These innovators will no longer have […].
Healthcare IT Today
AUGUST 1, 2023
This funding empowers Parker Health to further its position as the industry’s most compliant and competitive solution helping expand our medical technology and services and to employ global teams. Parker Health has raised $26.3 million to date.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
MAY 5, 2024
Dedicated Facilities: The new EIT Oxford campus includes over 30,000 square meters of research laboratory space, an oncology and wellness clinic, and facilities like AI GPU Supercluster Lab, Drug Design Lab, and Medical Device Lab, specifically dedicated to healthcare technology advancements.
Digital Health Global
MARCH 16, 2023
We believe our pioneering technology will allow us to shatter the boundaries that exist in gene editing methods today,” said Anne-K. Both Wellington and Forbion are visionaries and highly experienced biotech investors, and we look forward to working closely with them in our efforts to transform the gene editing landscape.” “Our
Healthcare Innovation Consortium
OCTOBER 24, 2023
We aim to bring together relevant stakeholders, including payers, providers, patients groups, and biotech and when and where needed we cooperate with pharma, to be the one voice of the industry. Inna: Our aim is to improve patient and clinician access to modern, innovative and reliable medical technology.
Health Populi
JANUARY 8, 2019
As my friends at #JPM this week are hearing in San Francisco, AI is part of virtually every biotech and med-tech story. Digging deeper into some of the big trends, Shelly’s observations will also ring authentic to health/care stakeholders… AI is everywhere at CES. But it’s not necessarily useful for everything.
Digital Health Global
FEBRUARY 5, 2024
Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics.
Expert insights. Personalized for you.
79 
Let's personalize your content